| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2024―Jul―23 |
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group |
Anne Mea Spanjaart, Per Ljungman, Gloria Tridello, Juana Schwartz, Nuria Martinez-Cibrián, Pere Barba, Mi Kwon, Lucia Lopez-Corral, Joaquin Martinez-Lopez, Christelle Ferra, Roberta Di Blasi, Hervé Ghesquieres, Pim Mutsaers, Friso Calkoen, Margot Jak, Jaap van Doesum, Joost S. P. Vermaat, Marjolein van der Poel, Johan Maertens, Massimiliano Gambella, Elisabetta Metafuni, Fabio Ciceri, Riccardo Saccardi, Emma Nicholson, Eleni Tholouli, Collin Matthew, Victoria Potter, Adrian Bloor, Caroline Besley, Claire Roddie, Keith Wilson, Arnon Nagler, Antonio Campos, Soeren Lykke Petersen, Frantisek Folber, Peter Bader, Jurgen Finke, Nicolaus Kroger, Nina Knelange, Rafael de La Camara, Marie José Kersten, Stephan Mielke |
| 2 |
[GO] |
2023―Dez―04 |
Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients |
Julius C. Enssle, Julia Campe, Alina Moter, Isabel Voit, Alec Gessner, Weijia Yu, Sebastian Wolf, Björn Steffen, Hubert Serve, Melanie Bremm, Sabine Huenecke, Michael Lohoff, Maria Vehreschild, Holger F. Rabenau, Marek Widera, Sandra Ciesek, Thomas Oellerich, Katharina Imkeller, Michael A. Rieger, Ivana von Metzler, Evelyn Ullrich |
| 3 |
[GO] |
2023―Jul―28 |
The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial |
J. Hammersen, S. Birndt, K. Döhner, P. Reuken, A. Stallmach, P. Sauerbrey, F. La Rosée, M. Pfirrmann, C. Fabisch, M. Weiss, K. Träger, H. Bremer, S. Russo, G. Illerhaus, D. Drömann, S. Schneider, P. La Rosée, A. Hochhaus |
| 4 |
[GO] |
2023―Jul―28 |
Convalescent plasma for patients with multiple myeloma and COVID-19; the European Myeloma Network consensus |
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Ioannis Ntanasis-Stathopoulos, Pieter Sonneveld, Heinz Ludwig |
| 5 |
[GO] |
2023―Jul―17 |
Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9) |
Simone Cesaro, Malgorzata Mikulska, Hans H. Hirsch, Jan Styczynski, Sylvain Meylan, Catherine Cordonnier, Davide Navarro, Marie von Lilienfeld-Toal, Varun Mehra, Francesco Marchesi, Caroline Besson, Raul Cordoba Masculano, Gernot Beutel, Herman Einsele, Johan Maertens, Rafael de la Camara, Marie von Lilienfeld-Toal, Rafael de la Camara, Per Ljungman, Livio Pagano |
| 6 |
[GO] |
2023―Jun―22 |
COVID-19 convalescent plasma retains value for immunocompromised patients |
Daniele Focosi, Massimo Franchini |
| 7 |
[GO] |
2023―Mai―04 |
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN) |
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Gordon Cook, Francesca Gay, Niels W. C. J. van de Donk, Ioannis Ntanasis-Stathopoulos, Annette Juul Vangsted, Christoph Driessen, Fredrik Schjesvold, Claudio Cerchione, Sonja Zweegman, Roman Hajek, Philippe Moreau, Hermann Einsele, Jesus San-Miguel, Mario Boccadoro, Meletios A. Dimopoulos, Pieter Sonneveld, Heinz Ludwig |
| 8 |
[GO] |
2023―Apr―10 |
The impact of Covid-19 in patients with chronic myeloid leukemia-a nationwide population-based study |
Torsten Dahlén, Hjalmar Flygt, Anna Lübking, Ulla Olsson-Strömberg, Lovisa Wennström, Arta Dreimane, Anders Själander, Susannah Leach, Magnus Gisslén, Huiqi Li, Martin Höglund, Leif Stenke, Fredrik Nyberg |
| 9 |
[GO] |
2022―Dez―17 |
COVID-19 vaccine boosted immunity against Omicron in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors |
Dragana Milojkovic, Catherine J. Reynolds, Diana Mūnoz Sandoval, Franziska P. Pieper, Siyi Liu, Corinna Pade, Joseph M. Gibbons, Áine McKnight, Sandra Loaiza, Renuka Palanicawander, Andrew J. Innes, Simone Claudiani, Jane F. Apperley, Daniel M. Altmann, Rosemary J. Boyton |
| 10 |
[GO] |
2022―Okt―26 |
Temporal changes of the incidence of childhood B-cell precursor acute lymphoblastic leukaemia in Germany during the COVID-19 pandemic |
Arndt Borkhardt, Joachim Schüz, Claudia Trübenbach, Maike Wellbrock, Claudia Spix, Friederike Erdmann |
| 11 |
[GO] |
2022―Aug―13 |
Covid-19 in Philadelphia-negative myeloproliferative neoplasms: a GIMEMA survey on incidence, clinical management and vaccine |
M. Breccia, A. Piciocchi, M. Messina, S. Soddu, V. De Stefano, M. Bellini, A. Iurlo, B. Martino, S. Siragusa, F. Albano, B. Mora, P. Fazi, M. Vignetti, P. Guglielmelli, F. Palandri |
| 12 |
[GO] |
2022―Jun―27 |
Changes in multiple myeloma treatment patterns during the early COVID-19 pandemic period |
Natalia Neparidze, Rong Wang, Amer M. Zeidan, Nikolai A. Podoltsev, Rory M. Shallis, Xiaomei Ma, Amy J. Davidoff, Scott F. Huntington |
| 13 |
[GO] |
2022―Apr―29 |
Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9) |
Simone Cesaro, Per Ljungman, Malgorzata Mikulska, Hans H. Hirsch, Marie von Lilienfeld-Toal, Catherine Cordonnier, Sylvain Meylan, Varun Mehra, Jan Styczynski, Francesco Marchesi, Caroline Besson, Fausto Baldanti, Raul Cordoba Masculano, Gernot Beutel, Herman Einsele, Elie Azoulay, Johan Maertens, Rafael de la Camara, Marie von Lilienfeld-Toal, Rafael de la Camara, Livio Pagano |
| 14 |
[GO] |
2022―Feb―25 |
Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patients |
Joan How, Kathleen M. E. Gallagher, Yiwen Liu, Katelin Katsis, Eva L. Elder, Rebecca C. Larson, Mark B. Leick, Donna Neuberg, Marcela V. Maus, Gabriela S. Hobbs |
| 15 |
[GO] |
2022―Feb―01 |
Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis |
Thomas Hueso, Anne-Sophie Godron, Emilie Lanoy, Jérôme Pacanowski, Laura I. Levi, Emmanuelle Gras, Laure Surgers, Amina Guemriche, Jean-Luc Meynard, France Pirenne, Salim Idri, Pierre Tiberghien, Pascal Morel, Caroline Besson, Rémy Duléry, Sylvain Lamure, Olivier Hermine, Amandine Gagneux-Brunon, Nathalie Freymond, Sophie Grabar, Karine Lacombe |
| 16 |
[GO] |
2022―Jan―21 |
Second versus first wave of COVID-19 in patients with MPN |
Tiziano Barbui, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Greta Carioli, Marta Anna Sobas, Elena Maria Elli, Elisa Rumi, Valerio De Stefano, Francesca Lunghi, Monia Marchetti, Rosa Daffini, Mercedes Gasior Kabat, Beatriz Cuevas, Maria Laura Fox, Marcio Miguel Andrade-Campos, Francesca Palandri, Paola Guglielmelli, Giulia Benevolo, Claire Harrison, Maria Angeles Foncillas, Massimiliano Bonifacio, Alberto Alvarez-Larran, Jean-Jacques Kiladjian, Estefanía Bolaños Calderón, Andrea Patriarca, Keina Quiroz Cervantes, Martin Griessammer, Valentin Garcia-Gutierrez, Alberto Marin Sanchez, Elena Magro Mazo, Marco Ruggeri, Juan Carlos Hernandez-Boluda, Santiago Osorio, Gonzalo Carreno-Tarragona, Miguel Sagues Serrano, Rajko Kusec, Begona Navas Elorza, Anna Angona, Blanca Xicoy Cirici, Emma Lopez Abadia, Steffen Koschmieder, Daniele Cattaneo, Cristina Bucelli, Edyta Cichocka, Anna Masternak Kulikowska de Nałęcz, Fabrizio Cavalca, Oscar Borsani, Silvia Betti, Lina Benajiba, Marta Bellini, Natalia Curto-Garcia, Alessandro Rambaldi, Alessandro Maria Vannucchi |
| 17 |
[GO] |
2021―Dez―22 |
SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia |
Sibylle C. Mellinghoff, Sandra Robrecht, Leonie Mayer, Leonie M. Weskamm, Christine Dahlke, Henning Gruell, Kanika Vanshylla, Hans A. Schlösser, Martin Thelen, Anna-Maria Fink, Kirsten Fischer, Florian Klein, Marylyn M. Addo, Barbara Eichhorst, Michael Hallek, Petra Langerbeins |
| 18 |
[GO] |
2021―Nov―08 |
Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group |
Anne Mea Spanjaart, Per Ljungman, Rafael de La Camara, Gloria Tridello, Valentín Ortiz-Maldonado, Alvaro Urbano-Ispizua, Pere Barba, Mi Kwon, Dolores Caballero, Pierre Sesques, Emmanuel Bachy, Roberta Di Blasi, Catherine Thieblemont, Friso Calkoen, Pim Mutsaers, Johan Maertens, Livia Giannoni, Emma Nicholson, Matthew Collin, Carlos Pinho Vaz, Elisabetta Metafuni, Joaquin Martinez-Lopez, Fiona L. Dignan, Josep-Maria Ribera, Arnon Nagler, Frantisek Folber, Robin Sanderson, Adrian Bloor, Fabio Ciceri, Nina Knelange, Francis Ayuk, Nicolaus Kroger, Marie José Kersten, Stephan Mielke |
| 19 |
[GO] |
2021―Nov―05 |
Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines |
Kathryn E. Kozak, Linda Ouyang, Andriy Derkach, Alexandra Sherman, Susan J. McCall, Christopher Famulare, Jordan Chervin, Ryan J. Daley, Sejal Morjaria, Michael J. Mauro, Raajit K. Rampal |
| 20 |
[GO] |
2021―Nov―01 |
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study |
Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò, Georgios Karakatsoulis, David Allsup, Alejandro Alonso Cabrero, Martin Andres, Darko Antic, Mónica Baile, Panagiotis Baliakas, Dominique Bron, Antonella Capasso, Sofia Chatzileontiadou, Raul Cordoba, Juan-Gonzalo Correa, Carolina Cuéllar-García, Lorenzo De Paoli, Maria Rosaria De Paolis, Giovanni Del Poeta, Christos Demosthenous, Maria Dimou, David Donaldson, Michael Doubek, Maria Efstathopoulou, Barbara Eichhorst, Shaimaa El-Ashwah, Alicia Enrico, Blanca Espinet, Lucia Farina, Angela Ferrari, Myriam Foglietta, Henrik Frederiksen, Moritz Fürstenau, José A. García-Marco, Rocío García-Serra, Massimo Gentile, Eva Gimeno, Andreas Glenthøj, Maria Gomes da Silva, Odit Gutwein, Yervand K. Hakobyan, Yair Herishanu, José Ángel Hernández-Rivas, Tobias Herold, Idanna Innocenti, Gilad Itchaki, Ozren Jaksic, Ann Janssens, Оlga B. Kalashnikova, Elżbieta Kalicińska, Linda Katharina Karlsson, Arnon P. Kater, Sabina Kersting, Jorge Labrador, Deepesh Lad, Luca Laurenti, Mark-David Levin, Enrico Lista, Alberto Lopez-Garcia, Lara Malerba, Roberto Marasca, Monia Marchetti, Juan Marquet, Mattias Mattsson, Francesca R. Mauro, Ivana Milosevic, Fatima Mirás, Marta Morawska, Marina Motta, Talha Munir, Roberta Murru, Carsten U. Niemann, Raquel Nunes Rodrigues, Jacopo Olivieri, Lorella Orsucci, Maria Papaioannou, Miguel Arturo Pavlovsky, Inga Piskunova, Viola Maria Popov, Francesca Maria Quaglia, Giulia Quaresmini, Kristian Qvist, Gianluigi Reda, Gian Matteo Rigolin, Rosa Ruchlemer, Gevorg Saghumyan, Amit Shrestha, Martin Šimkovič, Martin Špaček, Paolo Sportoletti, Oana Stanca, Niki Stavroyianni, Tamar Tadmor, Doreen Te Raa, Sanne H. Tonino, Livio Trentin, Ellen Van Der Spek, Michel van Gelder, Roel van Kampen, Marzia Varettoni, Andrea Visentin, Candida Vitale, Ewa Wasik-Szczepanek, Tomasz Wróbel, Lucrecia Yáñez San Segundo, Mohamed Yassin, Marta Coscia, Alessandro Rambaldi, Emili Montserrat, Robin Foà, Antonio Cuneo, Kostas Stamatopoulos, Paolo Ghia |
| 21 |
[GO] |
2021―Sep―25 |
Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients |
Lisa Blixt, Gordana Bogdanovic, Marcus Buggert, Yu Gao, Sophia Hober, Katie Healy, Hemming Johansson, Christian Kjellander, Sara Mravinacova, Sandra Muschiol, Peter Nilsson, Marzia Palma, Elisa Pin, C. I. Edvard Smith, Olga Stromberg, Margaret Sällberg Chen, Rula Zain, Lotta Hansson, Anders Österborg |
| 22 |
[GO] |
2021―Sep―13 |
Publisher Correction: The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS) |
Andreas Neubauer, Johannes Johow, Elisabeth Mack, Andreas Burchert, Damaris Meyn, Andrea Kadlubiec, Iuliu Torje, Hinnerk Wulf, Claus F. Vogelmeier, Joachim Hoyer, Chrysanthi Skevaki, Ralf Michael Muellenbach, Christian Keller, Carmen Schade-Brittinger, Caroline Rolfes, Thomas Wiesmann |
| 23 |
[GO] |
2021―Sep―07 |
The impact of specific cytokine directed treatment on severe COVID-19 |
P. A. Reuken, M. M. Rüthrich, A. Hochhaus, J. Hammersen, M. Bauer, P. La Rosée, F. La Rosée, A. Stallmach |
| 24 |
[GO] |
2021―Aug―12 |
The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS) |
Andreas Neubauer, Johannes Johow, Elisabeth Mack, Andreas Burchert, Damaris Meyn, Andrea Kadlubiec, Iuliu Torje, Hinnerk Wulf, Claus F. Vogelmeier, Joachim Hoyer, Chrysanthi Skevaki, Ralf Michael Muellenbach, Christian Keller, Carmen Schade-Brittinger, Caroline Rolfes, Thomas Wiesmann |
| 25 |
[GO] |
2021―Jul―29 |
Response to mRNA vaccination for COVID-19 among patients with multiple myeloma |
Samuel D. Stampfer, Marissa-Skye Goldwater, Scott Jew, Sean Bujarski, Bernard Regidor, David Daniely, Haiming Chen, Ning Xu, Mingjie Li, Tracy Green, Eddie Fung, Elias Aquino, Regina Swift, Shahrooz Eshaghian, Kurt Preugschat, Aaron J. Feinstein, Tanya M. Spektor, James R. Berenson |
| 26 |
[GO] |
2021―Jun―28 |
Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19 |
Giuseppe Gritti, Federico Raimondi, Barbara Bottazzi, Diego Ripamonti, Ivano Riva, Francesco Landi, Leonardo Alborghetti, Marco Frigeni, Marianna Damiani, Caterina Micò, Stefano Fagiuoli, Ferdinando Luca Lorini, Lucia Gandini, Luca Novelli, Jonathan P. Morgan, Benjamin M. J. Owens, Karan J. K. Kanhai, Gordana Tonkovic Reljanovic, Marco Rizzi, Fabiano Di Marco, Alberto Mantovani, Alessandro Rambaldi |
| 27 |
[GO] |
2021―Jun―23 |
An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner |
Magdalena Kucia, Janina Ratajczak, Kamila Bujko, Mateusz Adamiak, Andrzej Ciechanowicz, Vira Chumak, Katarzyna Brzezniakiewicz-Janus, Mariusz Z. Ratajczak |
| 28 |
[GO] |
2021―Jun―02 |
COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey |
Per Ljungman, Rafael de la Camara, Malgorzata Mikulska, Gloria Tridello, Beatriz Aguado, Mohsen Al Zahrani, Jane Apperley, Ana Berceanu, Rodrigo Martino Bofarull, Maria Calbacho, Fabio Ciceri, Lucia Lopez-Corral, Claudia Crippa, Maria Laura Fox, Anna Grassi, Maria-Jose Jimenez, Safiye Koçulu Demir, Mi Kwon, Carlos Vallejo Llamas, José Luis López Lorenzo, Stephan Mielke, Kim Orchard, Rocio Parody Porras, Daniele Vallisa, Alienor Xhaard, Nina Simone Knelange, Angel Cedillo, Nicolaus Kröger, José Luis Piñana, Jan Styczynski |
| 29 |
[GO] |
2021―Mai―24 |
Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19 |
Giuseppe Gritti, Federico Raimondi, Barbara Bottazzi, Diego Ripamonti, Ivano Riva, Francesco Landi, Leonardo Alborghetti, Marco Frigeni, Marianna Damiani, Caterina Micò, Stefano Fagiuoli, Ferdinando Luca Lorini, Lucia Gandini, Luca Novelli, Jonathan P. Morgan, Benjamin M. J. Owens, Karan J. K. Kanhai, Gordana Tonkovic Reljanovic, Marco Rizzi, Fabiano Di Marco, Alberto Mantovani, Alessandro Rambaldi |
| 30 |
[GO] |
2021―Mai―22 |
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms |
Patrick Harrington, Hugues de Lavallade, Katie J. Doores, Amy O’Reilly, Jeffrey Seow, Carl Graham, Thomas Lechmere, Deepti Radia, Richard Dillon, Yogita Shanmugharaj, Andreas Espehana, Claire Woodley, Jamie Saunders, Natalia Curto-Garcia, Jennifer O’Sullivan, Kavita Raj, Shahram Kordasti, Michael H. Malim, Claire N. Harrison, Donal P. McLornan |
| 31 |
[GO] |
2021―Mai―18 |
Seroconversion and dynamics of the anti-SARS-CoV-2 antibody response related to a hospital COVID-19 outbreak among pediatric oncology patients |
Nikolay Mayanskiy, Polina Luchkina, Natalia Fedorova, Yuri Lebedin, Natalia Ponomareva |
| 32 |
[GO] |
2021―Mai―17 |
Systematic review and meta-analysis of tocilizumab in persons with coronavirus disease-2019 (COVID-19) |
Chong-xiang Chen, Fang Hu, Jin Wei, Le-tao Yuan, Tian-meng Wen, Robert Peter Gale, Yang Liang |
| 33 |
[GO] |
2021―Mai―14 |
JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis |
Chong-xiang Chen, Jiao-jiao Wang, Huan Li, Le-tao Yuan, Robert Peter Gale, Yang Liang |
| 34 |
[GO] |
2021―Mai―13 |
COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia |
Lindsey E. Roeker, David A. Knorr, Meghan C. Thompson, Mariely Nivar, Sonia Lebowitz, Nicole Peters, Isaac Deonarine, Saddia Momotaj, Saumya Sharan, Vanessa Chanlatte, Bianca Hampton, Liana Butala, Lindsay Amato, Angela Richford, Jessica Lunkenheimer, Kristen Battiato, Carissa Laudati, Anthony R. Mato |
| 35 |
[GO] |
2021―Mai―04 |
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines |
Michael Grever, Leslie Andritsos, Versha Banerji, Jacqueline C. Barrientos, Seema Bhat, James S. Blachly, Timothy Call, Matthew Cross, Claire Dearden, Judit Demeter, Sasha Dietrich, Brunangelo Falini, Francesco Forconi, Douglas E. Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B. Johnston, Gunnar Juliusson, Eric Kraut, Robert J. Kreitman, Francesco Lauria, Gerard Lozanski, Sameer A. Parikh, Jae Park, Aaron Polliack, Farhad Ravandi, Tadeusz Robak, Kerry A. Rogers, Alan Saven, John F. Seymour, Tamar Tadmor, Martin S. Tallman, Constantine S. Tam, Enrico Tiacci, Xavier Troussard, Clive Zent, Thorsten Zenz, Pier Luigi Zinzani, Bernhard Wörmann |
| 36 |
[GO] |
2021―Mrz―17 |
Ruxolitinib withdrawal due to the COVID-19 |
Marko Lucijanic, Rajko Kusec |
| 37 |
[GO] |
2021―Feb―25 |
Response to: Ruxolitinib withdrawal due to the COVID-19 |
Tiziano Barbui, Alessandra Carobbio |
| 38 |
[GO] |
2021―Feb―20 |
Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection |
Philipp A. Reuken, Andreas Stallmach, Mathias W. Pletz, Christian Brandt, Nico Andreas, Sabine Hahnfeld, Bettina Löffler, Sabine Baumgart, Thomas Kamradt, Michael Bauer |
| 39 |
[GO] |
2021―Feb―13 |
Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm |
Richard A. Salisbury, Natalia Curto-Garcia, Jennifer O’Sullivan, Frederick Chen, Paolo Polzella, Anna L. Godfrey, James Russell, Steven Knapper, John Willan, Rebecca Frewin, Shivani Joshi, Siamak Arami, Sarah Burns, Chun Huat Teh, Frances Wadelin, Jaymathi Dhanapal, Pratap Neelakantan, Dragana Milojkovic, Beth Psaila, Richard Szydlo, Sebastian Francis, Catherine Cargo, Manish Jain, Andrew McGregor, Louise Wallis, Andrew Duncombe, Hayder Hussein, Peter Dyer, Laura Munro, Lee Bond, Mary Frances McMullin, Tim C. P. Somervaille, Mamta Garg, Mallika Sekhar, Claire Harrison, Adam J. Mead, Andrew J. Innes |
| 40 |
[GO] |
2021―Jan―07 |
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib |
Tiziano Barbui, Alessandro Maria Vannucchi, Alberto Alvarez-Larran, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Alberto Ferrari, Giuseppe Rossi, Elena Elli, Marcio Miguel Andrade-Campos, Mercedes Gasior Kabat, Jean-Jaques Kiladjian, Francesca Palandri, Giulia Benevolo, Valentin Garcia-Gutierrez, Maria Laura Fox, Maria Angeles Foncillas, Carmen Montoya Morcillo, Elisa Rumi, Santiago Osorio, Petros Papadopoulos, Massimiliano Bonifacio, Keina Susana Quiroz Cervantes, Miguel Sagues Serrano, Gonzalo Carreno-Tarragona, Marta Anna Sobas, Francesca Lunghi, Andrea Patriarca, Begona Navas Elorza, Anna Angona, Elena Magro Mazo, Steffen Koschmieder, Marco Ruggeri, Beatriz Cuevas, Juan Carlos Hernandez-Boluda, Emma Lopez Abadia, Blanca Xicoy Cirici, Paola Guglielmelli, Marta Garrote, Daniele Cattaneo, Rosa Daffini, Fabrizio Cavalca, Beatriz Bellosillo, Lina Benajiba, Natalia Curto-Garcia, Marta Bellini, Silvia Betti, Valerio De Stefano, Claire Harrison, Alessandro Rambaldi |
| 41 |
[GO] |
2020―Dez―09 |
SARS-CoV-2 antibody responses in patients with acute leukaemia |
J. O’Nions, L. Muir, J. Zheng, C. Rees-Spear, A. Rosa, C. Roustan, C. Earl, P. Cherepanov, R. Gupta, A. Khwaja, C. Jolly, L. E. McCoy |
| 42 |
[GO] |
2020―Nov―10 |
Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia |
A. D’Alessio, P. Del Poggio, F. Bracchi, G. Cesana, N. Sertori, D. Di Mauro, A. Fargnoli, M. Motta, C. Giussani, P. Moro, G. Vitale, M. Giacomini, G. Borra |
| 43 |
[GO] |
2020―Okt―26 |
COVID-19 and myeloproliferative neoplasms: some considerations |
Baransel Kamaz, Ann Mullally |
| 44 |
[GO] |
2020―Sep―02 |
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 |
Alessandro Gozzetti, Enrico Capochiani, Monica Bocchia |
| 45 |
[GO] |
2020―Aug―25 |
COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey |
Massimo Breccia, Alfonso Piciocchi, Valerio De Stefano, Guido Finazzi, Alessandra Iurlo, Paola Fazi, Stefano Soddu, Bruno Martino, Francesca Palandri, Sergio Siragusa, Francesco Albano, Francesco Passamonti, Marco Vignetti, Alessandro M. Vannucchi |
| 46 |
[GO] |
2020―Aug―19 |
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study |
Alessandro M. Vannucchi, Benedetta Sordi, Alessandro Morettini, Carlo Nozzoli, Loredana Poggesi, Filippo Pieralli, Alessandro Bartoloni, Alessandro Atanasio, Filippo Miselli, Chiara Paoli, Giuseppe G. Loscocco, Andrea Fanelli, Ombretta Para, Andrea Berni, Irene Tassinari, Lorenzo Zammarchi, Laura Maggi, Alessio Mazzoni, Valentina Scotti, Giorgia Falchetti, Danilo Malandrino, Fabio Luise, Giovanni Millotti, Sara Bencini, Manuela Capone, Marie Pierre Piccinni, Francesco Annunziato, Paola Guglielmelli |
| 47 |
[GO] |
2020―Aug―14 |
COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter |
Ankur Varma, Satyajit Kosuri, Celalettin Ustun, Uroosa Ibrahim, Jonathan Moreira, Michael R. Bishop, Sunita Nathan, Jayesh Mehta, Daniel Moncayo, Joseph Heng, Keren Osman, Kehinde U. A. Adekola |
| 48 |
[GO] |
2020―Aug―07 |
Reduction in the rate and improvement in the prognosis of COVID-19 in haematological patients over time |
Chiara Cattaneo, Chiara Pagani, Valeria Cancelli, Luisa Imberti, Aldo M. Roccaro, Luigi D. Notarangelo, Giuseppe Rossi |
| 49 |
[GO] |
2020―Aug―04 |
Reply to “CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report” Analysis of six hematological centers in Lombardy |
Gianluigi Reda, Alessandro Noto, Ramona Cassin, Giulia Zamprogna, Chiara Borella, Lydia Scarfò, Lucia Farina, Alfredo Molteni, Paolo Ghia, Alessandra Tedeschi, Marco Montillo |
| 50 |
[GO] |
2020―Jul―20 |
Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission |
Qiubai Li, Lei Chen, Qin Li, Wenjuan He, Jianming Yu, Li Chen, Yulin Cao, Wenlan Chen, Fang Dong, Liling Cai, Qijie Ran, Lei Li, Qiaomei Liu, Wenxiang Ren, Fei Gao, Hongxiang Wang, Zhichao Chen, Robert Peter Gale, Yu Hu |
| 51 |
[GO] |
2020―Jul―09 |
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus |
Lydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin, Giulia Quaresmini, Marina Motta, Candida Vitale, Jose Antonio Garcia-Marco, José Ángel Hernández-Rivas, Fatima Mirás, Mónica Baile, Juan Marquet, Carsten U. Niemann, Gianluigi Reda, Talha Munir, Eva Gimeno, Monia Marchetti, Francesca Maria Quaglia, Marzia Varettoni, Julio Delgado, Sunil Iyengar, Ann Janssens, Roberto Marasca, Angela Ferrari, Carolina Cuéllar-García, Gilad Itchaki, Martin Špaček, Lorenzo De Paoli, Luca Laurenti, Mark-David Levin, Enrico Lista, Francesca R. Mauro, Martin Šimkovič, Ellen Van Der Spek, Elisabeth Vandenberghe, Livio Trentin, Ewa Wasik-Szczepanek, Rosa Ruchlemer, Dominique Bron, Maria Rosaria De Paolis, Giovanni Del Poeta, Lucia Farina, Myriam Foglietta, Massimo Gentile, Yair Herishanu, Tobias Herold, Ozren Jaksic, Arnon P. Kater, Sabina Kersting, Lara Malerba, Lorella Orsucci, Viola Maria Popov, Paolo Sportoletti, Mohamed Yassin, Barbara Pocali, Gabor Barna, Annalisa Chiarenza, Gimena dos Santos, Eugene Nikitin, Martin Andres, Maria Dimou, Michael Doubek, Alicia Enrico, Yervand Hakobyan, Olga Kalashnikova, Macarena Ortiz Pareja, Maria Papaioannou, Davide Rossi, Nimish Shah, Amit Shrestha, Oana Stanca, Niki Stavroyianni, Vladimir Strugov, Constantine Tam, Mihnea Zdrenghea, Marta Coscia, Kostas Stamatopoulos, Giuseppe Rossi, Alessandro Rambaldi, Emili’ Montserrat, Robin Foà, Antonio Cuneo, Paolo Ghia |
| 52 |
[GO] |
2020―Jul―08 |
Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study |
Geneviève I. C. G. Ector, Elisabeth G. W. Huijskens, Nicole M. A. Blijlevens, Peter E. Westerweel |
| 53 |
[GO] |
2020―Jul―08 |
Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands |
Jaap van Doesum, Anabelle Chinea, Maria Pagliaro, Maria Cristina Pasquini, Tom van Meerten, Martijn Bakker, Emanuele Ammatuna |
| 54 |
[GO] |
2020―Jul―03 |
How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy-a GIMEMA MPN WP survey |
Francesca Palandri, Alfonso Piciocchi, Valerio De Stefano, Massimo Breccia, Guido Finazzi, Alessandra Iurlo, Paola Fazi, Stefano Soddu, Bruno Martino, Sergio Siragusa, Francesco Albano, Francesco Passamonti, Marco Vignetti, Alessandro M. Vannucchi |
| 55 |
[GO] |
2020―Jun―29 |
COVID-19 among fit patients with CLL treated with venetoclax-based combinations |
Moritz Fürstenau, Petra Langerbeins, Nisha De Silva, Anna Maria Fink, Sandra Robrecht, Julia von Tresckow, Florian Simon, Karin Hohloch, Jolanda Droogendijk, Marjolein van der Klift, Ellen van der Spek, Thomas Illmer, Björn Schöttker, Kirsten Fischer, Clemens M. Wendtner, Eugen Tausch, Stephan Stilgenbauer, Carsten U. Niemann, Michael Gregor, Arnon P. Kater, Michael Hallek, Barbara Eichhorst |
| 56 |
[GO] |
2020―Jun―19 |
Impact of Covid-19 on the treatment of acute myeloid leukemia |
Felicetto Ferrara, Patrizia Zappasodi, Elisa Roncoroni, Erika Borlenghi, Giuseppe Rossi |
| 57 |
[GO] |
2020―Jun―18 |
Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey |
Massimo Breccia, Elisabetta Abruzzese, Monica Bocchia, Massimiliano Bonifacio, Fausto Castagnetti, Carmen Fava, Sara Galimberti, Antonella Gozzini, Gabriele Gugliotta, Alessandra Iurlo, Roberto Latagliata, Luigiana Luciano, Patrizia Pregno, Giovanna Rege-Cambrin, Gianantonio Rosti, Fabio Stagno, Mario Tiribelli, Robin Foà, Giuseppe Saglio |
| 58 |
[GO] |
2020―Jun―18 |
Regional BCG vaccination policy in former East- and West Germany may impact on both severity of SARS-CoV-2 and incidence of childhood leukemia |
Julia Hauer, Ute Fischer, Franziska Auer, Arndt Borkhardt |
| 59 |
[GO] |
2020―Jun―17 |
Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS) |
Andreas Neubauer, Thomas Wiesmann, Claus F. Vogelmeier, Elisabeth Mack, Chrysanthi Skevaki, Christine Gaik, Christian Keller, Jens Figiel, Kristina Sohlbach, Caroline Rolfes, Harald Renz, Hinnerk Wulf, Andreas Burchert |
| 60 |
[GO] |
2020―Jun―16 |
Risk factors for death in 1859 subjects with COVID-19 |
Lei Chen, Jianming Yu, Wenjuan He, Li Chen, Guolin Yuan, Fang Dong, Wenlan Chen, Yulin Cao, Jingyan Yang, Liling Cai, Di Wu, Qijie Ran, Lei Li, Qiaomei Liu, Wenxiang Ren, Fei Gao, Hongxiang Wang, Zhichao Chen, Robert Peter Gale, Qiubai Li, Yu Hu |
| 61 |
[GO] |
2020―Jun―11 |
Hematological features of persons with COVID-19 |
Qiubai Li, Yulin Cao, Lei Chen, Di Wu, Jianming Yu, Hongxiang Wang, Wenjuan He, Li Chen, Fang Dong, Weiqun Chen, Wenlan Chen, Lei Li, Qijie Ran, Qiaomei Liu, Wenxiang Ren, Fei Gao, Zhichao Chen, Robert Peter Gale, Yu Hu |
| 62 |
[GO] |
2020―Jun―11 |
Holding CoVID in check through JAK? The MPN-approved compound ruxolitinib as a potential strategy to treat SARS-CoV-2 induced systemic hyperinflammation |
F. Heidel, A. Hochhaus |
| 63 |
[GO] |
2020―Jun―09 |
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation |
F. La Rosée, H. C. Bremer, I. Gehrke, A. Kehr, A. Hochhaus, S. Birndt, M. Fellhauer, M. Henkes, B. Kumle, S. G. Russo, P. La Rosée |
| 64 |
[GO] |
2020―Jun―01 |
Multiple myeloma and COVID-19 |
Binod Dhakal, Anita D’Souza, Saurabh Chhabra, Parameswaran Hari |
| 65 |
[GO] |
2020―Jun―01 |
SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine “storm” and risk factor for damage of hematopoietic stem cells |
Mariusz Z. Ratajczak, Magda Kucia |
| 66 |
[GO] |
2020―Mai―22 |
Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN) |
Evangelos Terpos, Monika Engelhardt, Gordon Cook, Francesca Gay, Maria-Victoria Mateos, Ioannis Ntanasis-Stathopoulos, Niels W. C. J. van de Donk, Hervé Avet-Loiseau, Roman Hajek, Annette Juul Vangsted, Heinz Ludwig, Sonja Zweegman, Philippe Moreau, Hermann Einsele, Mario Boccadoro, Jesus San Miguel, Meletios A. Dimopoulos, Pieter Sonneveld |
| 67 |
[GO] |
2020―Mai―19 |
CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report |
Tycho Baumann, Julio Delgado, Emili Montserrat |
| 68 |
[GO] |
2020―Mai―05 |
Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis |
Huan Li, Chongxiang Chen, Fang Hu, Jiaojiao Wang, Qingyu Zhao, Robert Peter Gale, Yang Liang |
| 69 |
[GO] |
2020―Mai―01 |
Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases |
Marie von Lilienfeld-Toal, Jörg Janne Vehreschild, Oliver Cornely, Livio Pagano, Francesca Compagno, Hans H. Hirsch |
| 70 |
[GO] |
2020―Apr―24 |
COVID-19 in persons with haematological cancers |
Wenjuan He, Lei Chen, Li Chen, Guolin Yuan, Yun Fang, Wenlan Chen, Di Wu, Bo Liang, Xiaoting Lu, Yanling Ma, Lei Li, Hongxiang Wang, Zhichao Chen, Qiubai Li, Robert Peter Gale |
|
